Core Concept - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Momentum investing can be risky as stocks may lose momentum if their valuations exceed future growth potential, leading to potential losses for investors [2] - A safer approach may involve investing in bargain stocks that are experiencing recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Case Study - 3D Systems (DDD) - 3D Systems has shown a price increase of 3.1% over the past four weeks, indicating growing investor interest [4] - The stock has gained 80.2% over the past 12 weeks, with a beta of 2.11, suggesting it moves significantly more than the market [5] - DDD has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to DDD's Zacks Rank 2 (Buy), as increased analyst interest typically drives stock prices higher [7] - DDD is trading at a Price-to-Sales ratio of 0.93, suggesting it is undervalued relative to its sales, providing room for further price appreciation [7] Group 4: Additional Opportunities - Besides DDD, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting additional investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]

Core Insights - The individual investor emphasizes a diversified investment approach, incorporating fundamental, technical, and momentum investing strategies to enhance their investment process [1]. Investment Approach - The investor believes in the merits of various investment strategies, including fundamental investing, technical analysis, and momentum investing, to create a well-rounded investment methodology [1]. Purpose of Writing - The intention behind writing on Seeking Alpha is to track the performance of investment ideas and connect with like-minded investors who share similar interests [1].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Lincoln Electric Holdings (LECO) - Lincoln Electric Holdings currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, LECO shares increased by 3.11%, while the Zacks Manufacturing - Tools & Related Products industry rose by 3.58% [5] - In a longer timeframe, LECO shares have risen by 8.42% over the past three months and 24.1% over the last year, outperforming the S&P 500, which increased by 7.07% and 16.3%, respectively [6] Trading Volume - The average 20-day trading volume for LECO is 284,814 shares, which serves as a useful indicator of price movement and market interest [7] Earnings Outlook - In the past two months, four earnings estimates for LECO have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $9.62 to $9.71 [9] - For the next fiscal year, four estimates have also moved higher without any downward revisions [9] Conclusion - Considering the strong momentum indicators and positive earnings outlook, LECO is identified as a 2 (Buy) stock with a Momentum Score of A, making it a promising candidate for near-term investment [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: US Gold Corp (USAU) - US Gold Corp currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The stock has shown significant price changes, with a 56.31% increase over the past three months and a 172.39% increase over the past year, outperforming the S&P 500's 7.07% and 16.3% respectively [7] Price Performance - Over the past week, USAU shares increased by 0.17%, while the Zacks Mining - Gold industry rose by 1.64% [6] - The monthly price change for USAU is 9.33%, compared to the industry's 0.08% [6] Trading Volume - The average 20-day trading volume for USAU is 430,767 shares, indicating a bullish sign if the stock price rises with above-average volume [8] Earnings Outlook - In the last two months, one earnings estimate for USAU has increased, raising the consensus estimate from -$0.65 to -$0.60 [10] - For the next fiscal year, one estimate has moved upwards with no downward revisions [10] Conclusion - Given the positive momentum indicators and earnings outlook, US Gold Corp is positioned as a promising investment opportunity with a Momentum Score of B [12]

Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher as stocks tend to continue in their established direction [1][2] - Argan (AGX) currently holds a Momentum Style Score of A and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [2][3] Performance Metrics - Over the past week, AGX shares increased by 10.85%, outperforming the Zacks Building Products - Miscellaneous industry, which rose by 2.04% [5] - In the last quarter, AGX shares rose by 17.99%, and over the past year, they have surged by 124.51%, while the S&P 500 only increased by 7.07% and 16.3% respectively [6] Trading Volume - The average 20-day trading volume for AGX is 338,666 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Estimates - In the past two months, one earnings estimate for AGX has increased, raising the consensus estimate from $6.95 to $7.75 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, AGX is positioned as a promising investment opportunity with a Momentum Score of A [10][11]

Investment Approach - The company emphasizes a diversified investment strategy that incorporates fundamental, technical, and momentum investing methods to enhance the investment process [1]. Purpose of Writing - The article serves as a platform for tracking investment ideas and connecting with like-minded investors who share similar interests in investment strategies [1].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Paranaense de Energia (ELP) - Paranaense de Energia currently holds a Momentum Style Score of B, indicating potential for solid momentum [3] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Performance Metrics - ELP shares have increased by 6.63% over the past week, outperforming the Zacks Utility - Electric Power industry, which rose by 1.88% [6] - Over the last quarter, ELP shares have gained 18.58%, and over the past year, they have increased by 41.08%, while the S&P 500 has only moved 7.28% and 16.15%, respectively [7] - The average 20-day trading volume for ELP is 190,568 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for ELP has increased, raising the consensus estimate from $0.13 to $0.17 for the full year [10] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [10] Conclusion - Given the positive performance metrics and earnings outlook, ELP is identified as a promising stock for near-term investment opportunities [12]

Core Insights - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] - Aclaris Therapeutics (ACRS) currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The Zacks Rank for ACRS is 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - ACRS shares have increased by 1.6% over the past week, while the Zacks Medical - Drugs industry remained flat during the same period [5] - Over the past month, ACRS has shown a price change of 4.15%, significantly outperforming the industry's 0.45% [5] - In the last quarter, ACRS shares rose by 19.64%, and over the past year, they gained 66.12%, compared to the S&P 500's increases of 7.28% and 16.15%, respectively [6] Trading Volume - ACRS has an average 20-day trading volume of 1,004,293 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for ACRS has increased, while none have decreased, leading to a consensus estimate improvement from -$0.52 to -$0.51 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions, indicating positive earnings momentum [9] Conclusion - Aclaris Therapeutics is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for investors seeking short-term gains [11]

Core Insights - Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing medicines for cancer patients, attracting attention from momentum investors due to its recent performance and analyst projections [1] Price Targets and Performance - RBC Capital set a price target of $13 for Verastem, indicating a potential increase of 62.3% from the current stock price of $8.01 [2][6] - Zacks Investment Research assigned Verastem a Momentum Style Score of A, suggesting strong potential for continued positive performance, with a current trading price of $9.22 and a 1.9% gain over the past four weeks [3][6] - Wall Street analysts have a price target range for Verastem from $13 to $20, indicating potential increases of 41% to 116.9% [5][6] Stock Performance and Market Data - The stock price has recently decreased by 7.97% to $8.49, with a trading range today between $6.98 and $9.02, and a yearly range from a low of $2.95 to a high of $11.25 [4] - Verastem's market capitalization is approximately $522.2 million, with a trading volume of 4,762,954 shares on the NASDAQ exchange [4]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1]. Company Overview: Incyte (INCY) - Incyte currently holds a Momentum Style Score of B, indicating strong momentum characteristics [2]. - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3]. Performance Metrics - Over the past week, Incyte's shares have increased by 4.5%, while the Zacks Medical - Biomedical and Genetics industry remained flat [5]. - Incyte's shares have risen by 24.74% over the past quarter and 31.9% over the last year, significantly outperforming the S&P 500, which increased by 6.14% and 15.41% respectively [6]. Trading Volume - The average 20-day trading volume for Incyte is 1,637,505 shares, which serves as a bullish indicator when combined with rising stock prices [7]. Earnings Outlook - In the last two months, two earnings estimates for Incyte have been revised upwards, while one has been revised downwards, leading to an increase in the consensus estimate from $6.01 to $6.15 [9]. - For the next fiscal year, there have been two upward revisions and one downward revision in earnings estimates [9]. Conclusion - Given the positive momentum indicators and earnings outlook, Incyte is recommended as a stock to consider for near-term investment opportunities [10].